Jérôme Poupiot

Distinctive Serum miRNA Profile in Mouse Models of Striated Muscular Pathologies

Nicolas Vignier, Fatima Amor, Paul Fogel et al. · PLoS ONE · 2013 · 100 citations · Full text

Muscle Function, Engineering, Pathology +19

AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not α-sarcoglycan deficiency

Marc Bartoli, Jérôme Poupiot, A. Vulin et al. · Gene Therapy · 2007 · 79 citations

Molecular Physiology, Signal Transduction, Aav-mediated Delivery +9

Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies

Jérémy Rouillon, Jérôme Poupiot, Aleksandar Zocevic et al. · Human Molecular Genetics · 2015 · 76 citations · Full text

Muscle Function, Engineering, Pathology +24

Safety and Efficacy of AAV-Mediated Calpain 3 Gene Transfer in a Mouse Model of Limb-Girdle Muscular Dystrophy Type 2A

Marc Bartoli, Carinne Roudaut, Samia Martin et al. · Molecular Therapy · 2005 · 74 citations · Full text

Mechanobiology, Calpain 3, Muscle Function +15

Phenotypic Correction of α-Sarcoglycan Deficiency by Intra-arterial Injection of a Muscle-specific Serotype 1 rAAV Vector

Françoise Fougerousse, Marc Bartoli, Jérôme Poupiot et al. · Molecular Therapy · 2006 · 65 citations · Full text